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ABSTRACT 
QUANTIFICATION OF LOCAL HEMODYNAMIC ALTERATIONS CAUSED BY 
VIRTUAL IMPLANTATION OF THREE COMMERCIALLY-AVAILABLE STENTS 
FOR THE TREATMENT OF AORTIC COARCTATION 
Sung Kwon 
Marquette University, 2013 
Patients with coarctation of the aorta (CoA) are prone to morbidity including 
atherosclerotic plaque that has been shown to correlate with altered wall shear stress 
(WSS) in the descending thoracic aorta (dAo). We created the first patient-specific 
computational fluid dynamics (CFD) model of a CoA patient treated by Palmaz stenting, 
and compared resulting WSS distributions to those from virtual implantation of the 
NumedCP and GenesisXD stents also commonly used for CoA. CFD models were 
created from magnetic resonance, fluoroscopy and blood pressure (BP) data. Simulations 
incorporated vessel deformation, downstream vascular resistance and compliance to 
match measured data and generate blood flow velocity and time-averaged WSS 
(TAWSS) results. TAWSS was quantified longitudinally and circumferentially in the 
stented region and dAo. While modest differences were seen in the distal portion of the 
stented region, marked differences were observed downstream along the posterior dAo 
and depended on stent type. The GenesisXD model had the least area of TAWSS values 
exceeding the threshold for platelet aggregation in vitro, followed by the Palmaz and 
NumedCP stents. Alterations in local blood flow patterns and WSS imparted on the dAo 
appear to depend on the type of stent implanted for CoA. These findings may aid 
pediatric interventional cardiologists in choosing the most appropriate stent for each 
patient, and ultimately reduce long-term morbidity following treatment for CoA by 
stenting.
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Chapter I. Introduction 
1.1 Coarctation of the Aorta 
Congenital heart defects, which are structural or vascular problems that arise from 
abnormal formation of the heart or major vessels, affects 9 out of 1000 live births, or 
36,000 infants each year in the United States(1).  Coarctation of the aorta (CoA) is one of 
the most common congenital heart defects (8-11%), and affects 5,000 to 8,000 births 
annually in the United States(1,2).  
CoA is characterized by a stenosis of the proximal descending thoracic aorta. The 
stenosis is typically located just distal to the left subclavian artery, or the juxtaductal part 
of the aorta, which is the region where the ductus arteriosus is attached (3) as shown in 
Figure 1.  
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Figure 1. Diagram of the CoA location relative to other vessels. 
CoA occurs just distal to head and neck vessels: A = Ductal coarctation, B = Pre-
ductal coarctation, C = post-ductal coarctation. Other numbers indicate vascular 
regions of interest pertinent to the current investigation including 1 = ascending aorta, 
2 = pulmonary artery, 3 = ductus arteriosus, 4 = descending aorta, 5 = innominate 
artery, 6 = left common carotid artery and 7 = left subclavian artery. Adapted from 
(4)     
 
 
The exact mechanism on how CoA forms is still unknown. In utero, the ductus 
arteriosus connects the pulmonary artery and the transverse aortic arch in order to pump 
the blood to the descending aorta. After birth, the ductus arteriosus closes within hours or 
days. It is speculated that either abnormal blood flow through the ductus or extension of 
ductal tissue into the aorta develop aortic obstruction as the ductus closes (3). CoA can 
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often be a cause for congestive heart failure of newborns between 2 weeks to 1 month 
old; however, CoA is asymptomatic in most patients and is diagnosed later in life for 
hypertension, murmurs or exercise intolerance. CoA can be diagnosed during a physical 
examination by measuring differences in upper and lower extremity blood pressure. A 
pressure difference of 20 mmHg is widely used as the threshold for diagnosing CoA. 
CoA can be also confirmed by echocardiography and magnetic resonance imaging (MRI) 
modalities. 
1.2 Associated effects of CoA 
CoA is associated with other cardiovascular defects including ventricular septal 
defect, atrial septal defect, aortic stenosis, mitral insufficiency, interrupted arch, and, 
most commonly (~80% of cases) bicuspid aortic valve. A stenosis along the aorta causes 
a markedly increased pressure gradient between the proximal and distal areas of the 
coarctation and this pressure gradient is typically measured to assess the severity of the 
condition. If untreated, patients are likely to develop life threatening conditions including, 
hypertension, cardiac dysfunction, early onset coronary artery disease, cerebral 
aneurysms, aortic aneurysms, aortic dissection, and stroke.    
1.3  Stent implantation as a treatment method for CoA 
Three main treatment options for CoA patients are surgical correction, balloon 
angioplasty, and stent implantation. While surgical correction has long been the mainstay 
of treatment, the less invasive nature, shorter hospitalization, reduced pain and decreased 
cost of catheter-based therapies has led to them playing an increasing role. In particular, 
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stent implantation has become a popular choice for the ability of stents to resist 
recoarctation more effectively than balloon angioplasty(3).  
Cardiovascular stents are used as vessel scaffolding to alleviate stenosis and 
restore blood flow to downstream vasculature. To date, stents have primarily been used to 
treat stenoses in coronary arteries, but applications of stents have extended for the 
treatment of peripheral arteries including  the carotid, renal and femoral arteries(5). Stent 
implantation to treat CoA has been gaining popularity since 1991 due to its less invasive 
technique compared to other treatment options including surgery and balloon angioplasty. 
Stent implantation can avoid overdilation, dissection, and elastic recoil of the aorta, and it 
can promote re-growth or healing of vessel by pinning intimal flaps to the vessel wall 
after the intimal and medial tear(6).  
Although variety of stents is used to treat CoA, off-label usage of biliary or iliac 
stents is typical due to the lack of Food and Drug Administration (FDA) approved stents 
to treat CoA. The Congenital Cardiovascular Interventional Study Consortium (CCISC) 
conducted a retrospective survey and found that out of 565 stent implantation procedures, 
98% of them were acutely successful. Success was defined by a reduction in the 
ascending to descending aortic systolic blood pressure gradient to a value less than 20 
mmHg immediately after the procedure. However, the long-term morbidity of stent 
implantation is not well known(7).   
1.4 Hemodynamic alterations after stent implantation for CoA  
Since the first clinical use of stents for CoA in 1991, numerous reports have 
shown their ability to successfully reduce the pressure gradient across a coarctation and 
generally restore the aorta to normal caliber(8-11). Measuring a pressure gradient across 
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coarctation reveals whether the narrowing of the vessel has been corrected successfully in 
the short-term, but it must be noted that it does not evaluate the long-term impact of the 
stent implantation.  
Although stents with various designs may satisfy the pressure gradient criteria for 
success, the geometry of stents used in other vascular beds is known to influence local 
flow disturbances(12-14) including indices of wall shear stress (WSS, defined as the 
tangential force per unit area exerted on a blood vessel as a result of flowing blood). 
LaDisa et al demonstrated that there is a positive correlation between the pattern of 
neointimal hyperplasia and regions with low WSS in the stented iliac arteries of 
rabbits(12). Wentzel et al. showed that the implantation of the stents in pig arteries causes 
changes in vessel geometry, which also results in deleterious alterations in WSS 
patterns(14).         
Interestingly, the alteration of WSS in the aorta has also been linked to 
cardiovascular pathologies. In a study of ten middle-aged adults with pre-existing 
plaques, areas of low time-averaged WSS (TAWSS) were found in a rotating pattern 
progressing down the descending thoracic aorta (dAo) and correlated with areas of 
atherosclerosis(15). Other studies have indicated excessively high WSS can also be 
deleterious by initiating platelet aggregation(16). Thus, geometric intricacies of the 
particular stent used to treat CoA may uniquely influence the likelihood and severity of 
future dAo pathology. Stent-induced local flow alterations may also be accentuated in 
cases of residual narrowing where even a modest reduction in diameter within the 
coarctation region can accelerate blood through the stent and further contribute to 
deleterious downstream flow alterations. Understanding the impact of stent design on 
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hemodynamic alterations for CoA patients will be critical to prevent long-term 
pathological conditions due to hemodynamic alterations in dAo. Unfortunately, no 
studies to date have characterized local WSS after stenting for CoA. 
1.5 Patient-specific computation fluid dynamics (CFD) simulation 
CFD enables detailed spatiotemporal quantification of hemodynamic indices, 
including WSS, using patient-specific models. CFD uses numerical methods to solve 
nonlinear differential equations such as the Navier-Stokes equation that describes fluid 
flow. Recently, CFD has been utilized for simulating blood flow in medical applications 
to quantify hemodynamic indices and assess their impact on vascular diseases. 
Advantages of using CFD over clinical data include, but are not limited to, visual 
capabilities, control of variables, and time and cost efficiencies. Recent improvement in 
medical imaging technology make it possible to perform CFD simulations based on MRI 
and blood pressure (BP) data instead of idealized vessels and steady flow values. This 
facilitates more accurate and reliable data by performing a realistic simulation of blood 
flow in a particular physiological region and condition of interest. The major advantage 
of CFD over clinical data in the current stenting research is its ability to compare the 
performance of a variety of stents in a single patient by incorporating stent geometry into 
a CFD model of the patient's vessel.  
In early days of patient-specific CFD simulations, most studies were performed to 
elucidate the role of hemodynamic indices in the progression of atherosclerosis at the 
carotid and coronary arteries(17). Over the years, CFD has been used to quantify 
hemodynamic indices in various vasculature regions and associated diseases with 
advances of medical imaging technology, imaging processing, and computational 
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capabilities. The influence of CFD has reached the field of endovascular stent design as 
well. In 2007, the Virtual Intracranial Stenting Challenge project demonstrated the 
reproducibility of CFD simulation techniques in patient-specific stented models of 
intracranial aneurysms(18).  
1.6 Quantification of hemodynamic indices using CFD CoA models 
Several CFD studies were conducted to understand long-term impact of CoA 
treatment options by quantifying hemodynamics using CoA models of various stages(19-
21). Detailed patterns of altered hemodynamic indices such as WSS have also been 
quantified and visualized in CoA models(19). Hemodynamic alterations of CoA patients 
treated with resection with end-to-end anastomosis surgical repair were also evaluated 
through patient-specific CFD simulations. The results predicted long-term atherosclerotic 
plaque progression patterns in the dAo after the surgical treatment(20). Finally, Coogan 
et al. quantified cardiac work and compared values between stented CoA vessel and 
controls using CFD simulations by varying wall properties to differentiate the stented 
region from the rest of the aorta(21); however the detailed impact of stent design on 
hemodynamic alterations in dAo of CoA patients has not been evaluated using patient-
specific CFD data. Quantifying hemodynamic indices in the dAo of CoA patients due to 
the stent implantation using patient-specific CFD simulation may ultimately provide 
clinicians with a tool to choose the best stent design for a specific patient based on local 
hemodynamic indices in the dAo. Previously, this could not be done with clinical data 
alone. This is an especially valuable for CoA = because there is no FDA approved stent 
for the condition.   
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1.7 Objective 
Although recent findings suggest that stent implantation for CoA can alleviate a 
blood pressure gradient, they cannot confirm the long-term results of treatment by this 
approach. Altered hemodynamic indices such as WSS are known to be a cause of onset 
and progression of cardiovascular diseases such as atherosclerosis, thrombosis, and vessel 
injury. Therefore, it is important to understand the influence of stent implantation on 
hemodynamic indices as a surrogate for long-term morbidity after this treatment. 
Understanding the impact of the stent design on the long-term result can potentially aid 
clinicians in choosing stents with particular design that can maximize the success of the 
treatment.  
Current medical and computing technologies allow quantification of 
hemodynamic indices using patient-specific CFD simulations. CFD also facilitates virtual 
treatment of CoA for comparison of hemodynamic alterations between stents in the same 
vessel. The objective of the current investigation was to create the first patient-specific 
CFD model of a patient treated for CoA by stenting, and compare distributions of WSS, 
mainly in dAo, to those resulting from virtual implantation of two other stents commonly 
used to treat CoA. This investigation will demonstrate the capability of current 
technology to assess the performance of different stent designs for CoA using patient-
specific CFD simulations.  
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Chapter II. Methods 
2.1 CFD model construction 
2.1.1 Creation of patient-specific CFD models without the stent 
A CFD model of the vasculature was created by converting medical imaging data 
into a geometrically representative computer model(22). MRI was performed for a patient 
previously treated for CoA by Palmaz stent placement (Cordis Corp., Miami Lakes, FL) 
as part of a clinically ordered imaging session and after IRB approval facilitating use of 
the data for computational modeling. Gadolinium-enhanced magnetic resonance 
angiography (MRA) was conducted to delineate vascular morphology(22,23) including 
the thoracic aorta, and the innominate (IA), left and right carotid (LCCA and RCCA),  
vertebraland left subclavian (LSA) arteries. Phase Contrast MRI (PC-MRI) was 
performed to calculate time-resolved volumetric blood flow(23) over the full cardiac 
cycle at the ascending aorta (AscAo) slightly above the aortic root (Figure 2). Upper and 
lower extremity supine BP were then measured using an automated sphygmometer cuff.  
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Figure 2. Time-varying blood flow calculated using PC-MRI data in the AscAo slightly 
above the aortic root 
 
 
MRA data was processed for gradient nonlinearities(24) before CFD models were 
constructed using the Simvascular software package (https://simtk.org). Magnetic field 
inhomogeneities from the stent caused signal dropout in the volumetric MRA data 
(Figure 3A). Fluoroscopic angiography data from the same time period (Figure 3B) was 
therefore used to extract the dimensions and guide positioning of the stent within the 
coarctation region.  
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Figure 3.  Mean intensity projection of MRI data (A) and an angiographic image of the 
same patient obtained by fluoroscopy (B). 
CFD models were constructed using the MRI data with diameters of the stented region 
extracted from the fluoroscopy data to account for signal dropout created by artifacts due 
to the implanted Palmaz stent. 
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 MRA data in DICOM image slice format was converted into 3D volume format 
(.vti) using eFilm (Merge Healthcare, Chicago, IL) software (Figure 4A). Simvascular 
was then used to find the centerline path for each vessel by manually locating spline 
points (Figure 4B). The lumen area along each vessel was identified by implementing 
automated level set and manual techniques to segment a 2D intensity window 
perpendicular to the paths of each vessel (Figure 4C). Dimensions extracted from 
fluoroscopy images were used to segment the lumen area along the stented region. 2D 
segments for each vessel were then lofted together to create the patient-specific CFD 
solid model without the stent (Figure 4D).      
 
  
Figure 4. Creating the patient-specific CFD model. 
MRA data converted to volumetric data (A). Centerline paths (B) of vessels and 2D 
lumen areas (C) along the vessels were segmented. A geometrically accurate patient 
specific CFD model (D) was then created by lofting the 2D segments of lumen areas. 
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2.1.2 Virtual implantation of stents 
Geometric characteristics (Table 1) of the implanted and two additional stents, 
Numed Cheatham Platinum (Hopkinton, NY) and Genesis XD (Cordis Corp.), were 
obtained from literature(25,26) and the drawing of one repeating unit (Figure 5) for each 
stent design was created in computer aided design (CAD) software (Solidworks Corp., 
Concord, MA). Each version was then  virtually implanted into a separate, but equivalent, 
CFD model of the patient's thoracic aorta before stenting using the methods described by 
Gundert et al(27). First, a cylinder was created with an arbitrary thickness substantially 
thicker than the stent's thickness, but with a length identical to the desired stents (Figure 
6A). The drawing of a repeating unit of a stent, shown in Figure 5, was sketched onto a 
plane adjacent to the cylinder and the geometry of a stent was mapped by wrapping the 
plane around the cylinder (Figure 6B). The cavity of a repeating unit was proliferated 
longitudinally and circumferentially using the “circular” and “linear” pattern functions in 
CAD (Figure 6C). Protruded solids were then extracted from the remainder of the solid 
model to complete a thickened version of the stent (Figure 6D). The path of the aorta was 
imported and the thick stent was placed at the precise location of the Palmaz stent, and 
oriented to align with the path of the aorta (Figure 6E) using “flex” function in CAD. 
Solid models of the unstented aorta were then thinned to match the thickness of each 
stent as shown in Table 1 (Figure 6F). The intersection between versions of each “thick 
stent” and their corresponding thinned unstented aortic solid models created the 
geometrically accurate solid model of each stent (Figure 6G). These stents were then 
subtracted from copies of the same patient-specific computational model to produce the 
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flow domain associated with each stent as shown in Figure 7. CFD models were then 
discretized into a finite element mesh as described in detail below.   
Table 1. Design attributes of stents virtually implanted for CoA 
 Palmaz NumedCP GenesisXD 
Thickness (mm) 0.312 0.254 0.173 
Strut width (mm) 0.338 0.300 
0.205 (macro) 
0.123 (micro) 
Number of 
circumferential 
repeating units 
14 8 11 
 
Number of 
longitudinal repeating 
units 
7 6 5 
 
Stent/Vessel contact 
area (mm
2
) 
243 128 106 
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Figure 5. CAD drawings of a single repeating unit for Palmaz(A), NumedCP(B), and 
GenesisXD(C) stent designs with dimensions of microns.  
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Figure 6. Solid model creation for each stent using CAD software.  
A cylinder with the length identical to the stent was created (A). The geometry of a 
repeating unit of the stent was subtracted from the cylinder (B). The cavity of a repeating 
unit was proliferated linearly and circumferentially throughout the cylinder (C). 
Protruded solids from both sides were extracted to create athick version of the stent (D). 
The path of the unstented solid model was imported and the thick stent model was placed 
and oriented to align with the aorta (E). The unstented solid model was imported after 
being thinned to match the thickness of each stent (F). Intersection between the thinned 
unstented vessel solid model and the thick stent was conducted by a Boolean operation 
(G) in order to create asolid model of each stent that could then be subtracted from 
identical versions of the unstented patient-specific model. 
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Figure 7. Flow domain associated with each stent.  
Palmaz (left), NumedCP (middle) and GenesisXD (right) stents created using computer 
aided design software (top row). These stents were then subtracted from copies of the 
same patient-specific computational model to produce the flow domain associated with 
each stent (bottom row). 
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2.2 Specification of boundary conditions.  
The AscAo PC-MRI waveform, as shown in Figure 2, was mapped to the inlet 
face of CFD models using a temporally varying plug flow profile. The distribution of 
blood flow to the head and neck arteries was estimated from a known relationship 
between their diameter and AscAo flow(28).  To replicate the physiological impact of 
vasculature distal to CFD model branches, three-element Windkessel model outlet 
boundary conditions were imposed at model outlets using a coupled-multidomain 
method(29,30) as previously applied to CoA patients(20). Vascular wall displacement 
was simulated using a membrane model(31) with patient-specific elastic material 
properties(19), while stents were assumed to be rigid(32).   
2.3 CFD simulations 
Simulations were performed using a novel stabilized finite element method to 
solve the conservation of mass (continuity), balance of fluid momentum (Navier-Stokes) 
and vessel wall elastodynamics equations until the flow rate and BP fields were periodic. 
Newtonian and incompressible fluid assumptions were employed (4 cP and 1.06 g/cm
3
, 
respectively) consistent with previous studies and upon consideration of shear rates in 
this portion of the vasculature(19,33). 
2.4 Mesh Independence 
Following creation, models were discretized into finite element meshes using 
MeshSim (Simmetrix, Clifton Park, NY). Initial anisotropic meshes corresponding to 
models with each stent type were refined using an adaptive method(34,35) to 
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automatically allocate elements based on the complexity of local flow patterns and reduce 
computational cost as compared to isotropic meshes. While this approach allowed for 
appropriate edge size within proximal intrastrut regions, the adaption process uses 
velocity information(34,35) and hence provided less control over the number of elements 
in regions of low velocity within the distal portion of the stented region. Fortunately, 
MeshSim also allows a user to explicitly define edge lengths near a given CFD model 
face, such as struts or the vessel wall, through its interface within Simvascular. Smooth 
transitions between differences in mesh density are then created between adjacent 
elements regardless of their size. In order to create meshes with element sizes adequate to 
resolve flow features throughout the entire stent, the element size within the proximal 
intrastrut and stent strut regions was determined from initial adapted simulations (Figure 
8) after mesh convergence, defined by less than 3% difference between TAWSS of 
successive meshes in the proximal intrastrut region. The numbers of elements in these 
initial adapted meshes were 5,149,055, 4,106,766, and 4,237,399, for the Palmaz, 
NumedCP and GenesisXD stents, respectively. For each stent, the three smallest elements 
from intrastrut areas and stented regions were extracted using ParaView (Kitware, Inc., 
Clifton Park, New York). Edge lengths of each extracted element were measured and the 
average length was calculated. Each element has four nodal points and the shortest 
distance between the node not located on the vessel surface plane and the vessel surface 
was also calculated (Figure 8). This distance is the thickness of the element and this 
calculation was repeated for all elements from intrastrut areas and stented regions. These 
dimensions (Table 2) were then assigned near stent struts as well as the vessel wall to 
create isotropic elements at a very high mesh density(Figure 9). The meshes created after 
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assigning these local mesh attributes contained 3,495,606, 3,409,167 and 3,977,508 
elements for the Palmaz, NumedCP and Genesis XD stents, respectively. The internal 
and unstented portions of meshes for each model were then adapted repeatedly until they 
reached ~8.3 million elements, which was adequate for similar CFD simulations(23), 
while the dimensions of elements in stented regions were preserved. The steps outlined 
above for the mesh refinement protocol that includes adaptation of an initial anisotropic 
mesh and adaptation of the refined meshwith specified local attributes within the stented 
region are summarized below for added clarity: 
1. Initial anisotropic meshes for each stent were refined using an adaptive 
method until mesh convergence (< 3% differences in WSS between 
successive meshes) was achieved at the proximal stented region.  
2. Edge lengths and thicknesses of elements located on the surface of the stented 
regions were determined based on smallest elements on the proximal stented 
regions of the converged meshes. 
3. New initial meshes were created using the edge lengths and thicknesses of 
elements on the surface of stented regions.  
4. Meshes were refined, except for surface elements in stented region, using an 
adaptive method until they reached ~8.3 million elements. 
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Table 2. Meshing attributes for the stented region of CFD simulations 
Dimension (mm) Palmaz NumedCP GenesisXD 
Edge length within intrastrut 
area 
 
0.144 0.135 0.120 
Element thickness for 
intrastrut area 
0.098 0.057 0.037 
Edge length along stent strut 
0.106 0.090 0.084 
Element thickness for stent 
strut 
0.086 0.035 0.048 
 
Figure 8. Estimation of the edge lengths and thicknesses of elements on the instrastrut 
vessel surface and stent struts. 
 For each stent, three surface elements from intrastrut and stented regions were extracted. 
The average edge lengths of the vessel surface planes were calculated. The thickness of 
each element was calculated by using the coordinates of three vessel surface nodes and 
the node not located on the vessel surface.     
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Figure 9. Image showing the meshing protocol applied for the stented region.  
An adaptive meshing process created elements of appropriate size in proximal intrastrut 
regions (A, top images), but regions of low velocity adjacent to stents struts and the distal 
portion of the stented region contained fewer and larger elements after the adaptive 
process. The minimum edge size of all elements within the proximal stented region after 
adapting was therefore determined and applied within the stented region for meshes 
containing ~8.3 million elements (B, bottom images).   
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To quantify the error associated with final meshes, the TAWSS results were 
visualized by unwrapping the surface geometry of the vessel along the inner 
curvature(19,33) and TAWSS indices were mapped into circumferential and longitudinal 
coordinates after each simulation. At the levels of proximal and distal stented regions and 
the dAo, TAWSS values were quantified every 0.1 degrees circumferentially by 
interpolating nearest TAWSS values (Figure 10). For smoother local data, each data point 
was filtered by 3 longitudinal points 2D moving averaging filter. Finally, TAWSS 
differences between successive meshes for locations in the proximal stented region were 
divided by TAWSS at spatially-equivalent regions, while TAWSS differences in the 
distal stented region with very low TAWSS were divided by average TAWSS in the dAo 
as reported in a prior CFD study(36).  
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Figure 10. TAWSS quantification used for for mesh convergence calculations. 
After each simulation, surface geometry was unwrapped and TAWSS indices were 
mapped onto longitudinal and circumferential coordinates. TAWSS at proximal and 
distal stented regions as well as the dAo were compared between successive meshes to 
calculate errors for use in evaluating mesh independence. 
 
2.5 Quantification 
As described in the Section 2.4, the surface geometry of the vessel at the inner 
curvature and results for TAWSS within the stented region and the dAo distal to the stent 
are shown in Figure 11. TAWSS values were then plotted circumferentially for proximal 
and distal regions of the stent as well as two locations along the dAo. TAWSS values 
were also plotted longitudinally along regions of particular interest within the dAo. To 
further delineate between local differences in TAWSS due to stent type, the area of the 
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dAo exposed to a high TAWSS threshold of 50 dyne/cm
2
 at which platelet aggregation 
occurs in vitro(16) was quantified. In addition, peak and mean Reynolds numbers were 
calculated at the stented region for each stent. Reynolds (Re) number is used to 
characterize the fluid flow, such as laminar or turbulent flow. It was calculated by the 
equation shown below.  
 
Re = ρvD / µ 
 
ρ = density of blood 
v = velocity of blood flow 
D = diameter of the stented region 
µ = dynamic viscosity of blood     
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Figure 11. Approach for TAWSS quantification  
TAWSS values were quantified circumferentially at proximal and distal stented regions 
and two locations distal to the stent, as well as longitudinally along the left and right sides 
of the outer curvature. 
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Chapter III. Results 
3.1 Mesh Convergence 
After all stented models were refined to reach approximately 8.3 million meshes, 
TAWSS errors were <9% within the stented region between the two latest meshes for 
each stented model. (Table 3). The circumferential average of TAWSS on the surface of 
dAo at 4mm upstream from the outlet of the CFD model was consistent throughout all 
meshes. Errors at proximal stented regions were significantly lower than those from distal 
stented regions. Among stented models, the Palmaz stent had the lowest errors and 
NumedCP stent had the largest errors. In overall, the magnitude of errors reduced as 
meshes were refined. 
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Table 3. Mesh convergence results. 
Palmaz 
Number of 
elements 
TAWSS at 
the dAo 
(dyn/cm
2
) 
Comparison 
% error at 
the distal 
stented 
region 
% error at the 
proximal 
stented region 
Mesh 1 3,495,606 N/A N/A N/A N/A 
Mesh 2 3,693,418 N/A N/A N/A N/A 
Mesh 3 4,157,478 33.3 Mesh 2 vs Mesh 3 4.40 3.44 
Mesh 4 5,216,609 34.4 Mesh 3 vs Mesh 4 4.12 3.38 
Mesh 5 6,251,205 33.7 Mesh 4 vs Mesh 5 2.37 2.50 
Mesh 6 7,116,057 34.9 Mesh 5 vs Mesh 6 2.56 2.30 
Mesh 7 8,371,221 33.7 Mesh 6 vs Mesh 7 4.04 2.10 
GenesisXD  
TAWSS at 
the dAo 
(dyn/cm
2
) 
Comparison 
% error at 
the distal 
stented 
region 
% error at the 
proximal 
stented region 
Mesh 1 3,977,508 N/A N/A N/A N/A 
Mesh 2 4,206,059 N/A N/A N/A N/A 
Mesh 3 5,180,314 33.7 Mesh 2 vs Mesh 3 11.67 5.99 
Mesh 4 6,223,007 33.2 Mesh 3 vs Mesh 4 8.67 4.23 
Mesh 5 6,821,393 33.5 Mesh 4 vs Mesh 5 7.75 3.10 
Mesh 6 8,194,977 34.6 Mesh 5 vs Mesh 6 4.60 2.78 
NumedCP  
TAWSS at 
the dAo 
(dyn/cm
2
) 
 
% error at 
the distal 
stented 
region 
% error at the 
proximal 
stented region 
Mesh 1 3,495,606 N/A N/A N/A N/A 
Mesh 2 3,693,418 N/A N/A N/A N/A 
Mesh 3 4,157,478 33.5 Mesh 2 vs Mesh 3 12.76 6.54 
Mesh 4 5,216,609 33.0 Mesh 3 vs Mesh 4 12.07 5.17 
Mesh 5 6,251,205 33.2 Mesh 4 vs Mesh 5 14.13 3.38 
Mesh 6 7,116,057 33.7 Mesh 5 vs Mesh 6 11.27 3.03 
Mesh 7 8,371,221 33.5 Mesh 6 vs Mesh 7 8.44 2.86 
 
 
3.2 CFD simulation results 
Pressure and flow results from final simulations using deformable blood vessel 
were compared to measured physiologic values (Table 4). Parameters in three-element 
Windkessel model boundary conditions were modified for each mesh so that the diastolic, 
systolic and pulse pressures of simulations matches the measured physiologic values. 
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Difference in pressure and flow in dAo between the deformable simulations and the 
physiological value did not exceed 5 mmHg and 6%, respectively, for all stented models. 
Pressure and flow between stented simulations were consistent.    
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Table 4. Pressure and flow differences between CFD simulation results and measured 
physiological values 
 
 
IA RCCA LCCA LSA Collateral 
dAo 
(Outlet) 
Palmaz 
 
Systolic 
Pressure 
(mmHg) 
1 -5 0 -1 -1 -5 
Diastolic 
Pressure 
(mmHg) 
0 0 0 0 0 0 
Pulse 
Pressure 
(mmHg) 
1 -5 0 -1 -1 -5 
Flow 
(%) 
3.5 5.0 4.7 6.6 6.8 5.7 
NumedCP 
Systolic 
Pressure 
(mmHg) 
1 -5 -1 -1 -1 -5 
Diastolic 
Pressure 
(mmHg) 
0 0 0 0 0 0 
Pulse 
Pressure 
(mmHg) 
1 -5 -1 -1 -1 -5 
Flow 
(%) 
3.6 5.1 4.7 6.6 6.8 5.7 
GenesisXD 
Systolic 
Pressure 
(mmHg) 
1 -6 -1 -2 -2 -4 
Diastolic 
Pressure 
(mmHg) 
0 0 0 0 0 0 
Pulse 
Pressure 
(mmHg) 
1 -6 -1 -2 -2 -4 
Flow 
(%) 
3.3 4.8 4.5 6.3 6.5 6.0 
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Elevated TAWSS values (e.g. >100 dyn/cm
2
) were observed within the proximal 
portion of the stented region and in the dAo 10 to 110 mm distal to the stent, with varying 
severity depending on stent type (Figure 12). The Palmaz stent showed two focal regions 
of elevated TAWSS in the dAo. The first initiated along the outer right luminal surface 
~10 mm distal to the stent and extended to the center and then the outer left surface over 
~40 mm. The second was located 75-100 mm distal to the stent along the outer right 
luminal surface. The NumedCP stent also displayed two focal regions of elevated 
TAWSS along the outer left and right luminal surfaces ~30 to 70 mm distal to the stent. 
In contrast, the GenesisXD stent displayed a single focal region of elevated TAWSS 
along center of the outer luminal surface from ~10 to 20 mm distal to the stent. The 
lowest TAWSS values (<25 dyn/cm
2
) appeared within the distal stented region and along 
the inner curvature of the proximal dAo 0 to 50 mm downstream regardless of the type of 
stent implanted.  
 Circumferential quantification revealed higher TAWSS along the outer portion of 
the stented region (Figure 12, locations 1 and 2), while TAWSS along the inner curvature 
did not exceed 20 dyn/cm
2
. Differences in TAWSS were more pronounced in the distal 
versus the proximal stented region. For example, TAWSS peaked at ~ 80 dyn/cm
2
 in the 
distal region of the GenesisXD simulation as compared to values >80 dyn/cm
2
 
throughout the entire proximal stented region. The Palmaz stent had the lowest value of 
peak TAWSS in the distal region (51.7 dyn/cm
2
) as compared to NumedCP (80.0 
dyn/cm
2
) and GenesisXD (82.4 dyn/cm
2
). The region with elevated TAWSS ~15 mm 
distal to the stent (Figure 12, location 3) was also quantified circumferentially. Spatial 
distributions of TAWSS were similar among stents with highest values along the outer 
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curvature (peak TAWSS of 95.7, 82.6 and 120.9 dyn/cm
2
 for Palmaz, NumedCP and 
GenesisXD, respectively) and low TAWSS values <25 dyn/cm
2
. Peak TAWSS ~45 mm 
distal to the stent (Figure 12, location 4) was located along the left outer luminal surface 
of the dAo for Palmaz and NumedCP (90.5 and 139.4 dyn/cm
2
respectively), while the 
GenesisXD had a more uniform TAWSS distribution with a peak value of 64.8 dyn/cm
2
 
along
 
the outer curvature.  
 Longitudinal quantification was additionally performed along regions of the dAo 
distal to the stent with elevated TAWSS. Distributions of TAWSS along the outer left 
luminal surface for NumedCP and Palmaz stents (Figure 12, location 5) were elevated 
between 20 mm and 110 mm with peak values of 168 and 110 dyn/cm
2
 as compared to 
49.3 dyn/cm
2
 for the GenesisXD. Differences in TAWSS along the right outer luminal 
surface (Figure 12, location 6) were less pronounced between stents with values for 
GenesisXD generally lower than others.  
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Figure 12. Distributions of time-averaged wall shear stress for the Palmaz, NumedCP, 
and GenesisXD stents.  
CFD results for the full model are shown next to spatial maps that have been unwrapped 
about the outer (posterior) surface for the stented region and the distal descending aorta. 
Circumferential and longitudinal plots are also shown at several locations: proximal 
stented region (1), distal stented region (2), 15 mm distal to the stent (3), 45 mm distal to 
the stent (4), as well as the left (5) and right (6) portions of the outer curvature. Note that 
values occurring atop stent struts have been removed to improve the legibility of plots. 
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Figure 13 shows the area of TAWSS in the dAo exceeding the threshold for 
platelet aggregation in vitro(16). The GenesisXD model had the least area of TAWSS 
above the threshold (Table 5) followed by the Palmaz and NumedCP stents. 
 
 
Figure 13. Locations of elevated time-averaged wall shear stress for the Palmaz, 
NumedCP, and GenesisXD stents.  
The full CFD model results are shown next to spatial maps that have been unwrapped 
about the outer (posterior) surface for the descending aorta distal to the stent. Regions 
with time-averaged wall shear stress above 50 dyn/cm
2
 have been made opaque. Values 
above this threshold have been previously correlated with platelet aggregation in vitro. 
 
Table 5. The area (mm
2
) of the descending thoracic luminal surface exposed time-
averaged wall shear stress above the threshold for platelet aggregation in vitro 
 Palmaz NumedCP GenesisXD 
Area (mm
2
) in descending aorta with 
TAWSS above the threshold (mm
2
) 
1880 2010 559 
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Peak and mean Re numbers from NumedCP and GenesisXD stents simulation 
results were compared to those from the Palmaz stent (Table 6), for further use in 
interpreting the findings above. 
  
Table 6. Comparisons of peak and mean Re numbers between stents 
viscosity (g/mms) 0.004 
  density (g/mm^3) 0.00106 
  stented region diameter (mm) 11.72 
  
    
 
 
Palmaz Numed Genesis 
Peak flow (ml/min) 11047 11041 11201 
Peak Re 5303 5300 5378 
% diff n/a 0.05 -1.40 
    
 
     
 
Palmaz Numed Genesis 
Mean flow (ml/min) 3678 3677 3688 
Mean Re 1766 1766 1771 
% diff n/a 0.02 -0.27 
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Chapter IV. Discussion 
The objective of the current investigation was to create the first patient-specific 
CFD model of a patient treated for CoA by stenting, and compare resulting distributions 
of WSS in the stent and dAo to those from virtual implantation of two other stents 
commonly used to treat CoA. This objective was motivated by stent implantation playing 
an increasing role in the treatment of CoA. Since currently there are no FDA-approved 
stents specifically designed for children and a limited number of CoA patients at any 
given center, recent studies have documented several fundamental concerns regarding the 
use of stents in a manner other than that for which they were intended (i.e. off-label). 
Among these concerns is the impact of stents on hemodynamic indices including blood 
flow, pressure and WSS. Registries such as the Congenital Cardiovascular Interventional 
Study Consortium (CCISC) have been formed to obtain data pertaining to concerns such 
as these across multiple institutions. The current work illustrates how CFD can also 
provide useful insight and scrutinize stent performance in a retrospective or a priori 
manner.  
The main finding of the current work is that alterations in local blood flow 
patterns and WSS imparted on the thoracic aorta in patients treated for CoA may 
uniquely depend on the type of stent implanted. While modest differences were seen in 
the distal portion of the stented region, marked differences were observed downstream 
along the posterior luminal surface of the dAo. It is important to note that the methods 
applied with CFD models in the current work were carefully controlled to isolate the 
influence of stent design. The overall vessel geometry, including residual narrowing of 
the vessel in the stented region, was consistent between simulations. Inlet and outlet 
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boundary conditions were also consistent for all models, resulting in <0.3% difference in 
the distribution of flow to the dAo between simulations for each stent type. The current 
results indicate adverse local flow alterations were least severe for the GenesisXD, for 
which regions of elevated TAWSS and variability at the specific locations quantified 
were smallest. In contrast, the Palmaz and NumedCP stents both contained a greater 
percentage of high TAWSS along the posterior dAo. These differences are likely rooted 
in the design attributes intrinsic to each stent. Attributes including strut thickness, 
proximity, angle relative to the primary flow direction and stent:lumen area ratio were 
generally predictive of potentially adverse distributions of WSS in prior 
studies(13,37,38). Since all stent struts disturb blood flow, thicker struts protrude further 
into the flow domain and increase the severity of these disturbances. Similarly, the 
relative ratio of stent-to-vessel area influences the total amount of the vessel wall exposed 
to potentially deleterious flow patterns. The angle of struts relative to the primary 
direction of fluid flow, together with the overall stent geometry, can also influence the 
severity of flow disturbances caused by a stent. Stents with their linkages primarily 
arranged longitudinally have the potential to cause less severe flow disruptions as 
compared to ring-and-link designs primarily arranged circumferentially. For example, 
when stents are expanded to larger diameters, as can occur with redilation for recurrent 
CoA, their overall linkage design becomes arranged in a less longitudinal manner causing 
adjacent layers of fluid to be redirected more abruptly as they pass through the stented 
region. In contrast, larger intrastrut regions aligned in the primary direction of fluid flow 
limit separation and stagnation between struts. The Palmaz stent modeled in the current 
investigation with the greatest strut thickness and width, number of circumferential and 
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longitudinal repeating units, and ratio of stent-to-vessel area showed two focal regions of 
elevated TAWSS in the dAo. The NumedCP stent with larger intrastrut area and only 
slightly thinner struts also displayed two focal regions of elevated TAWSS along the 
dAo. In contrast, the GenesisXD stent with the thinnest struts, large intrastrut regions, 
and ratio of stent-to-vessel area similar to the NumedCP stent displayed a single focal 
region of elevated TAWSS downstream of the stent.  
An analysis of Reynolds numbers may further explain the current results. The 
Reynolds number is a dimensionless parameter describing the ratio of convective inertial 
forces to viscous forces. Values <2,000 constitute laminar flow where adjacent layers of 
fluid move in layers without mixing, while those >2,000 are characterized as turbulent or 
transitional. Mean and peak Re in the dAo for the patient studied here were 
approximately 1,750 and 5,300, respectively. These Re suggest flow was generally 
laminar throughout the cardiac cycle, but there were undoubtedly portions of the cardiac 
cycle during which flow was transitional or turbulent. During these times modest 
differences in local vessel geometry caused by design attributes of a particular stent could 
cause perturbations resulting in irregular erratic intermingling of fluid particles 
downstream of the stent and manifest in the differences observed. 
 The current results may have important clinical implications as low TAWSS 
values are associated with the onset and progression of cardiovascular disease in many 
vascular beds(39), and TAWSS above a certain preferential value may be associated 
endothelial injury, plaque rupture, or thrombogenesis(40,41). For example, a previous 
study of healthy young adults found areas of adverse WSS in a rotating pattern 
progressing down the dAo(42). A second previous study of ten middle-aged adults with 
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pre-existing plaques revealed similar WSS patterns that correlated with areas of 
atherosclerosis(15). When joined with the results of the current investigation, the 
collective findings suggest the type of stent used to treat CoA may uniquely influence the 
location and severity of aortic plaque. In addition to vascular remodeling processes 
triggered by indices of WSS(43), local velocity jets and accompanying high TAWSS 
values imparted on the posterior wall due to a particular stent type may lead to tortuosity 
as seen in a rabbit model of CoA(44), or disturb the cushioning function of the thoracic 
aorta by increasing stiffness(45). However, these hypotheses remain to be tested in a 
follow-up study conducted with patients previously undergoing treatment of CoA using 
different stents.  
 While there are many publications quantifying outcomes from stenting as 
compared to surgery or balloon angioplasty, most of these studies have grouped 
outcomes from several stents together thereby resulting in a paucity of data comparing 
one stent type to another for metrics beyond stent fracture. To our knowledge, this is the 
first investigation to incorporate realistic stent geometries into an entire patient-specific 
thoracic aortic CFD model in order to quantify the impact of stent design on local 
hemodynamic alterations. While previous CFD studies involving stenting of the thoracic 
aorta provided invaluable information, they often included limitations such as omitting 
detailed geometric intricacies of a stent, used models restricted to the stented region, used 
idealized vessel models or did not include analysis of downstream hemodynamic 
alterations. The current investigation strongly suggests these downstream hemodynamic 
alterations unique to a given stent may be an important factor contributing to mechanical 
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stimuli, and likely influencing vascular remodeling or plaque formation, after treatment 
for CoA.  
The current results also extend the body of literature using CFD to study 
treatments for CoA by quantifying TAWSS alterations due to stent design. Previously 
Coogan et al. used a patient-specific CFD model of the thoracic aorta to study 
compliance mismatch created by making a portion of the dAo rigid, which had only a 
modest impact on cardiac work and blood pressure(21). The current results can also be 
appreciated relative to those from CFD models of untreated CoA patients and those 
corrected by end-to-end anastomosis or end-to-side repair that used methods equivalent 
to those employed here(19). The range of peak WSS in the dAo shown here seem to fall 
below the values observed with untreated patients (1,777-6,000 dyn/cm
2
), but were still 
more severe than those observed with surgically corrected or normal patients in this 
previous work.  
The current study should be interpreted with the constraints of several potential 
limitations. The strut cross section of the virtually implanted NumedCP was rectangular 
due to restrictions associated with the virtual stenting process, but the actual cross 
sectional shape of struts for this stent is circular. The use of a NumedCP stent with 
circular struts would likely decrease the severity of downstream hemodynamic alterations 
shown here. Future studies will strive to incorporate this realism. The prolapse of tissue 
into intrastrut regions was not considered here since the main focus was to quantify 
hemodynamic alterations downstream of the stented region and isolate the impact of 
different stent designs. Nevertheless, this factor should also be considered in future 
studies, perhaps using the approach Murphy el al. applied in CFD models of a stented 
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coronary artery(13). Although an analysis of mesh independence showed the difference 
in TAWSS between successive meshes generally reduced as meshes were refined, mesh 
independence could not be definitively concluded, as TAWSS difference between last 
two Palmaz meshes increased from previous successive meshes. It is possible even finer 
meshes are required for mesh independence, but the desktop computers used to refine 
meshes in our laboratory have limited capability in their RAM and are therefore unable to 
create meshes with a number of elements exceeding 8.3 million. Additional mesh 
independence studies are needed in future work. Each stented model underwent up to 15 
rigid wall simulations followed by a deformable wall simulation. Due to the large number 
of elements, it took approximately 2 months of computational time for each deformable 
simulation. Future modification of the mesh convergence strategy applied here and 
increased computational power may reduce the duration of future analyses. The Reynolds 
numbers quantified suggest that flow is transitional or turbulent during portions of the 
cardiac cycle. Error associated with analyzing transitional or turbulent flow using CFD 
software with a linear solver should be specifically quantified through comparison with 
results from CFD software that incorporates a turbulence model. Future studies can then 
implement other methods as needed to capture thenature of the transitional or turbulent 
flow more appropriately for future stented models of the aorta.       
While the detailed patterns of TAWSS shown here are influenced by stent type, 
general flow patterns through the thoracic aorta are also largely dictated by vessel 
morphology for the patient modeled and distributions of blood flow to the head and neck 
arteries. For example, the presence of elevated TAWSS in the proximal stented region 
was a function of patient morphology and may not have been present in a patient with a 
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gothic or crenel arch(46). Nonetheless, the current investigation demonstrates that the 
type of stent implanted can influence TAWSS distributions, which may be further 
accentuated or mitigated depending on a given patient's aortic morphology.  
 In summary, the current study is the first to quantify downstream hemodynamic 
alterations due to stenting in CoA patients using patient-specific CFD models with 
virtually implanted stents. The current results showed marked differences in TAWSS 
patterns in the downstream dAo depending on the stent implanted. Following 
confirmation with future studies, these findings may aid pediatric interventional 
cardiologists in choosing the most appropriate stent for each patient, and thereby reduce 
long-term morbidity following treatment for CoA by stenting. 
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